openPR Logo
Press release

Future of Eye Health: Macular Degeneration Treatment Market Trends 2024-2031 | Latest Major Companies likes - Novartis AG, Regeneron Pharmaceuticals Inc., Genentech USA, Inc., REGENXBIO Inc., Bausch Health Companies Inc.

04-25-2025 03:33 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Macular Degeneration Treatment Market

Macular Degeneration Treatment Market

The latest report published by DataM Intelligence highlights the growth prospects of Macular Degeneration Treatment market. The industry expansion is majorly driven by developments in technology across the globe.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/macular-degeneration-treatment-market?ca

The Global Macular Degeneration Treatment Market reached USD 9.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 15.3 billion by 2030. The global macular degeneration treatment market is expected to exhibit a CAGR of 6.6% during the forecast period (2023-2030).

Macular degeneration treatment focuses on slowing the progression of the disease and preserving vision. For age-related macular degeneration (AMD), options include anti-VEGF injections to reduce abnormal blood vessel growth, laser therapy, and nutritional supplements. In some cases, low vision aids and rehabilitation are recommended to help individuals adapt to vision loss.

Competitive Evaluation:

Companies covered in this report are Novartis AG, Regeneron Pharmaceuticals Inc., Genentech USA, Inc., REGENXBIO Inc., Bausch Health Companies Inc., F Hoffmann-La Roche Ltd, Santen Pharmaceutical Co., Ltd., GNH Pharmaceuticals USA LLC, Iveric Bio Inc., and Allergan, Inc.

The Macular Degeneration Treatment Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.

Key Development

On April 21, 2023, Janssen Pharmaceutical Companies of Johnson & Johnson announced five presentations at the ARVO 2023 Annual Meeting in New Orleans. These include updates from the Phase 1/2 MGT009 trial for botaretigene sparoparvovec (bota-vec) gene therapy in X-linked retinitis pigmentosa (XLRP) patients and pooled safety data from two Phase 1 trials of JNJ-81201887. The trials focus on geographic atrophy (GA) and wet age-related macular degeneration (AMD).

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/macular-degeneration-treatment-market?ca

Macular Degeneration Treatment Market Segments

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.

By Type: Wet Macular Degeneration, Dry Macular Degeneration

By Treatment: Drugs, Therapy, Surgery, Others

By End-User: Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Assessment:

Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Macular Degeneration Treatment market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

In terms of geographical analysis, Macular Degeneration Treatment Market report provides an in-depth view of:-

∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/macular-degeneration-treatment-market?ca

This report provides a 360-degree synopsis of the competitive scenario of the Macular Degeneration Treatment industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Browse More Reports: https://www.datamintelligence.com/research-report/macular-degeneration-treatment-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future of Eye Health: Macular Degeneration Treatment Market Trends 2024-2031 | Latest Major Companies likes - Novartis AG, Regeneron Pharmaceuticals Inc., Genentech USA, Inc., REGENXBIO Inc., Bausch Health Companies Inc. here

News-ID: 3988609 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Natural Caffeine Market: Supply Chain & Coffee Price Volatility | Major Companies - SHRI AHIMSA NATURALS LIMITED, Applied Food Sciences (AFS), Botanic Healthcare, Natura Vitalis
United States Natural Caffeine Market: Supply Chain & Coffee Price Volatility | …
Market Size and Forecast: Global Natural Caffeine Market reached US$ 3.4 billion in 2023 and is expected to reach US$ 5.27 billion by 2031, growing with a CAGR of 5.6% during the forecast period 2024-2031. The Natural Caffeine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and
United States Sustainable Pharmaceutical Packaging Market: 12.7% CAGR to US$ 316.05 Billion By 2033 | Top Most Keyplayers - Amcor plc, Berry Global Inc., Gerresheimer AG, WestRock Company
United States Sustainable Pharmaceutical Packaging Market: 12.7% CAGR to US$ 316 …
Market Size and Forecast: Sustainable Pharmaceutical Packaging Market size reached US$ 91.94 Billion in 2024 and is expected to reach US$ 316.05 Billion by 2033, growing at a CAGR of 12.7% during the forecast period 2025-2033, according to DataM Intelligence report. The Global Sustainable Pharmaceutical Packaging Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM
United States Ultra High Performance Concrete (UHPC) Market 2025 | Infrastructure Innovation & Sustainability Drive Global Growth
United States Ultra High Performance Concrete (UHPC) Market 2025 | Infrastructur …
DataM Intelligence has published a new research report on "Ultra High Performance Concrete Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Pre-packaged UHPC is priced at over
United States Automotive Artificial Intelligence (AI) Industry Sector Growth to 2031 | Leading Companies - German Autolabs, Raven, Argo AI, Deepscale, Cisco
United States Automotive Artificial Intelligence (AI) Industry Sector Growth to …
DataM Intelligence has published a new research report on "Automotive Artificial Intelligence Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample PDF Of This

All 5 Releases


More Releases for Macular

2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound
Macular Edema and Macular Degeneration Market Poised for 7.1% Growth, Set to Hit …
How Are the key drivers contributing to the expansion of the macular edema and macular degeneration market? The growth of the macular edema and macular degeneration market is predicted to be driven by the escalating number of individuals suffering from diabetes. Diabetes is a long-term health condition that results in elevated levels of glucose in the bloodstream. The condition harms the eye's blood vessels, potentially leading to macular edema and macular
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be? The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies. Download White Paper: https://www.towardshealthcare.com/download-statistics/5375 Market Overview and Key Drivers The macular
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $12.84
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The